Westaim Net Income/Loss 2010-2024 | WEDXD
Westaim net income/loss from 2010 to 2024. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
Westaim Annual Net Income/Loss
(Millions of US $) |
| 2023 |
$184 |
| 2022 |
$18 |
| 2021 |
$28 |
| 2020 |
$-34 |
| 2019 |
$9 |
| 2018 |
$17 |
| 2017 |
$6 |
| 2016 |
$-8 |
| 2015 |
$8 |
| 2014 |
$18 |
| 2013 |
$-4 |
| 2012 |
$-33 |
| 2011 |
$33 |
| 2010 |
$54 |
| 2009 |
$-5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
CHEM-SPECIALTY |
$0.461B |
$0.009B |
|
The Westaim Corporation is a technology accelerator that ensures its technology investments have the leadership, strategy, and capital to get into the marketplace as quickly as possible. Currently, Westaim has technology investments in three of the most important and fastest growing sectors of the economy: biomedical (Westaim Biomedical Corp.), semi-conductor/electronics (iFire Technology Inc.), and e-business software (Savvion).
|
